Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Depreciation and Depletion: 2022-2024

Historic Depreciation and Depletion for Candel Therapeutics (CADL) over the last 3 years, with Dec 2024 value amounting to $1.0 million.

  • Candel Therapeutics' Depreciation and Depletion rose 18.93% to $289,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $919,000, marking a year-over-year change of. This contributed to the annual value of $1.0 million for FY2024, which is negligibly% changed negligibly from last year.
  • Candel Therapeutics' Depreciation and Depletion amounted to $1.0 million in FY2024, which was down 0.00% from $1.0 million recorded in FY2023.
  • In the past 5 years, Candel Therapeutics' Depreciation and Depletion ranged from a high of $1.0 million in FY2023 and a low of $800,000 during FY2022.
  • Its 3-year average for Depreciation and Depletion is $933,333, with a median of $1.0 million in 2024.
  • Data for Candel Therapeutics' Depreciation and Depletion shows a peak YoY climbed of 25.00% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows Candel Therapeutics' Depreciation and Depletion stood at $800,000 in 2022, then increased by 25.00% to $1.0 million in 2023, then remained steady at $1.0 million in 2024.